The illegal distribution of "licit" pharmaceuticals is a somewhat neglected dimension of the African drugs trade, especially relative to the current focus on the trafficking of "hard" drugs through the region. Licit pharmaceutical substances do not generally have the strong psychoactive effects of the likes of heroin or cocaine, are more usually consumed for therapeutic purposes, and are widely accessible and in general socially accepted. However, they too can be dangerous to health, and are being illegally acquired and distributed. Thus, as items of consumption they are perceived to be different from other drugs discussed in this volume yet share certain dangers; as commodities often traded illegally, they are very similar, and can provide significant insight into the historical development of illicit trade networks in Africa. Indeed, the history of their illegal trade raises important questions about state control over drug use, distribution and public health, especially as their unregulated distribution could mean a lack of quality assurance and increased health risks for users-risks rarely appreciated in official discourse on illegal drugs and pharmaceuticals in Africa.
public health sector and broader global processes, showing that goods and bodies are moved along the same global trade routes. 4 In my 2010 article, I revisited Fassin's findings and expanded on them to not only consider regional networks but trans-regional networks extending to Europe and Asia. I also analyzed other manifestations of this illegal trade in the form of Keur Serigne Bi, an illegal market devoted primarily to the reselling of stolen pharmaceuticals.
5
This chapter builds on this research, examining the trade in such substances in Francophone West Africa, a region with a long history of illegal pharmaceutical sale and distribution, including the selling of controlled and prescription drugs without a license or government authorization.
6 Relying on government reports, interviews, archival records and other primary sources, this chapter highlights illegally acquired and traded pharmaceuticals in colonial and postcolonial West Africa.
7 It also considers the evolving nature of the trade and its key actors, including pharmacists. During the colonial era, pharmacists were commonly engaged in illegal drug distribution and sale, while in the postcolonial era, this trade has come under the control of other actors, including the Mouride Brotherhood. During this latter period, pharmacists mobilized periodically in attempts to reduce the parallel drug trade. Particular interest is given to these activities in Senegal, the seat of French colonial power in West Africa, with comparisons made to other colonial and postcolonial countries. The chapter also examines shifts in what "illegal" means in colonial French West Africa and independent Senegal, influenced by Jean and John Comaroff's-and others'-work on the intersections of the legal, extralegal, and criminal. 8 In particular, the motivating questions behind this inquiry are: who determines the illicitness of the sale of pharmaceuticals, and what feasible methods of punishment exist for those who are found liable?
In "Spaces of Engagement-How Borderlands, Illegal Flows, and Territorial States Interlock," Willem Van Schendel speaks to the difficulty in assessing illegal trading networks, arguing that borderlands "provide an excellent site to study the intermingling and overlapping of various legal and illegal flows" and that others may perceive these activities as legitimate. 9 In the case of Africa, many of its illegal transnational networks rely on the instability of borderlands, poor government enforcement, political corruption, informal markets, and social transition, all factors in the story of West Africa's pharmaceutical trade. Jean François Bayart, Stephen Ellis, and Béatrice Hibou address the criminalization of states and goods and the informal transnational trade in Africa. They argue that it is often difficult to identify what criminality means in Africa. 10 The intersections of the formal and the informal in certain transactions of pharmaceuticals can be an example of such an unclear distinction, similar to examples raised by Jean and John Comaroff. 11 In 2004, Politique Africaine published a special issue that addressed a number of extralegal economic activities including counterfeit products and psychoactive drug networks and several other
